Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)Recruiting
NCT06439277Phase 3Updated Aug 7, 2026
Sponsor: Eli Lilly and Company
Obesity · Weight Gain
United States, Argentina, Australia, Canada, France +7 more
Pridopidine Phase 3 Study in Huntington's DiseaseRecruiting
NCT07609108Phase 3Updated Aug 7, 2026
Sponsor: Prilenia
Huntington Disease
United States, Belgium, Canada, Czechia, France +7 more
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisRecruiting
NCT03773965Phase 3Updated Aug 7, 2026
Sponsor: Eli Lilly and Company
Juvenile Idiopathic Arthritis
Argentina, Australia, Austria, Belgium, Brazil +15 more
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent ChemoradiotherapyRecruiting
NCT06129864Phase 3Updated Aug 6, 2026
Sponsor: AstraZeneca
Locally Advanced Head and Neck Squamous Cell Carcinoma
United States, Austria, Belgium, Brazil, Canada +18 more
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema AttacksRecruiting
NCT06361537Phase 3Updated Aug 6, 2026
Sponsor: Octapharma
Acute Hereditary Angio Edema
United States, Albania, Argentina, Armenia, Bulgaria +8 more
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)Recruiting
NCT07223814Phase 3Updated Aug 6, 2026
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Acute Myeloid Leukemia
United States, Australia, Belgium, Estonia, Finland +4 more
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)Recruiting
NCT07566156Phase 3Updated Aug 6, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Urothelial Cancer · Urinary Bladder Neoplasms
United States
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseRecruiting
NCT07571161Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Alzheimer Disease
China
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerRecruiting
NCT06203210Phase 3Updated Aug 6, 2026
Sponsor: Daiichi Sankyo
Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsRecruiting
NCT07222137Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 1
United States, Australia, Belgium, Brazil, Canada +13 more
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)Recruiting
NCT06338995Phase 3Updated Aug 6, 2026
Sponsor: Eli Lilly and Company
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
United States, Argentina, Belgium, Bulgaria, Canada +15 more
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)Recruiting
NCT07059000Phase 3Updated Aug 6, 2026
Sponsor: Kedrion S.p.A.
Chronic Primary Immune Thrombocytopenia (ITP)
United States, Czechia, Germany, Italy, Romania +3 more
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisRecruiting
NCT07339111Phase 3Updated Aug 6, 2026
Sponsor: Medipost, Inc.
Knee Cartilage Defects
United States
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseRecruiting
NCT06585774Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
Chronic Graft-versus-host-disease
United States, Australia, Austria, Canada, Denmark +8 more
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerRecruiting
NCT06545955Phase 3Updated Aug 6, 2026
Sponsor: Ferring Pharmaceuticals
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
United States, Canada, Czechia, France, Poland +2 more
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult ParticipantsRecruiting
NCT06575192Phase 3Updated Aug 6, 2026
Sponsor: AbbVie
Breast Reconstruction
United States
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT06793215Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +23 more
A Study of DA-302168S in Participants With Overweight/ObesityRecruiting
NCT07629544Phase 3Updated Aug 6, 2026
Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD.
Overweight and Obesity
China
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsRecruiting
NCT06056297Phase 3Updated Aug 6, 2026
Sponsor: X4 Pharmaceuticals
Neutropenia
United States, Argentina, Australia, Belgium, Canada +20 more
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRecruiting
NCT07174310Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Parkinson's Disease
United States, Australia, Austria, Brazil, Canada +12 more
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruiting
NCT06973187Phase 3Updated Aug 6, 2026
Sponsor: BeOne Medicines
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States, Argentina, Australia, Austria, Belgium +19 more
Cardiovascular Protection After Preeclampsia With EnalaprilRecruiting
NCT07222852Phase 3Updated Aug 6, 2026
Sponsor: Women and Infants Hospital of Rhode Island
Preeclampsia · Hypertensive Disorder of Pregnancy · Hypertension · Gestational Hypertension
United States
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaRecruiting
NCT05976763Phase 3Updated Aug 6, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Mantle Cell Lymphoma
United States
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
NCT07522073Phase 3Updated Aug 6, 2026
Sponsor: Incyte Corporation
Solid Tumors
United States, Australia, Austria, Belgium, Canada +15 more
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia ARecruiting
NCT07416526Phase 3Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Germany, Hungary, Italy, Japan +5 more

Previous page Next page